Low BCR-ABL expression levels in hematopoietic precursor cells enable persistence of chronic myeloid leukemia under imatinibAshu Kumari, Andreas Burchert, Andreas Hochhaus et al.|Blood|2011Cited by 84
Persisting Chronic Myeloid Leukemia Stem and Progenitor Cells From Patients in Major Molecular Remission Under Imatinib Are Characterized by Low BCR/ABL Expression.Ashu Kumari, Andreas Burchert, Cornelia Brendel et al.|Blood|2009Cited by 0